Sharon Bio-Medicine gets MHRA approval for its Dehradun facility
Moneylife Digital Team 09 July 2010

Sharon Bio-Medicine Ltd said its formulation plant at Dehradun has been approved by UK-based Medicines and Health Care Product Regulatory Agency (MHRA).

The company, located in Raigad, Maharashtra, expect the sales to start in near future to the UK and Europe, Sharon Bio-Medicine said in a regulatory filing.

On Friday, Sharon Bio-Medicine shares closed 3.2% higher at Rs135 on the Bombay Stock Exchange, while the Sensex ended at 1% up at 17,833 points.

Free Helpline
Legal Credit